Table 2.
Distribution of 68Ga-PSMA avid sites of prostate cancer involvement
| No studies (%) | SUVmax (range) | |
|---|---|---|
| N = 319 | 72% | |
| Prostate | 193 (43%) | 11.3 (2–61) |
| Loco-regional spread | 51 (11%) | 13 (2–78) |
| Abdomino-pelvic nodal metastases | 129 (29%) | 12 (1.4–100) |
| Distant metastases | 158 (36%) | |
| Bone metastases | 111 (25%) | 12.5 (1.9–91) |
| Distant nodes | 29 (7%) | 11.3 (1.5–58) |
| Othera | 18 (4%) | 7.1 (1.8–14.6) |
a68Ga-PSMA avid metastases in lungs (n = 10, 48%), liver (n = 5, 21%), brain (n = 2, 10%), pleura (n = 2, 10%), spleen (n = 1) and peritoneum (n = 1)